Fig. 7

A-B The ADORA2B drug sensitivity was positively correlated with the semi-inhibitory concentration of the drug, which was significant. C-D The expression of ADORA2B in esophageal cancer was verified by qRT-PCR and WB experiments( *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001)